Analytical note on comparative legislation on the regulation of the therapeutic use of ketamine for the treatment of post-traumatic stress disorders in Europe, the United States and Israel
Published on 25 October 2024, 15:17Abstract. The Analytical note presents the results of a study of the legal provisions regulating the therapeutic use of ketamine for the treatment of post-traumatic stress disorders. Attention is focused on the ongoing debate about the risks of ketamine use in psychotherapy. The results of scientific research are presented, in particular, on the bioavailability of ketamine in the treatment of mental illness.
Key words: ketamine, medicines, controlled substances, post-traumatic stress disorder, resistant depression, evidence-based medicine, ketamine infusion therapy.
09/2024